ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,227Medicare Part D Prescriptions Filled, Including Refills

Rank: 168 out of 1844

$497K Total Retail Price of All Prescriptions

Rank: 362 out of 1844

376 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

45% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 4,726 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,361 481 S3 1 2
OMEPRAZOLE 374 174 2 5
GABAPENTIN 259 113 3 15
SIMVASTATIN 246 100 4 3
FUROSEMIDE 243 103 5 7
CARISOPRODOL 239 77 R 6 128
LISINOPRIL-HYDROCHLOROTHIAZIDE 223 72 7 20
LISINOPRIL 217 118 8 4
PROAIR HFA 209 68 9 45
METOPROLOL TARTRATE 199 142 10 11
METFORMIN HCL 188 93 11 8
AMLODIPINE BESYLATE 186 118 12 6
LEVOTHYROXINE SODIUM 183 67 13 1
ZOLPIDEM TARTRATE 182 82 14 23
SERTRALINE HCL 174 48 15 21
GLIPIZIDE 173 72 16 70
ISOSORBIDE MONONITRATE ER 147 115 17 59
CEPHALEXIN 143 50 18 56
PROMETHAZINE HCL 137 46 R 19 88
RANITIDINE HCL 132 52 20 38
HYDROCHLOROTHIAZIDE 130 77 21 9
POTASSIUM CHLORIDE 124 70 22 16
WARFARIN SODIUM 119 71 23 13
ALPRAZOLAM 109 36 24 124
CYCLOBENZAPRINE HCL 106 0 R 25 53
NEXIUM 103 31 26 31
TAMSULOSIN HCL 90 49 27 27
ATENOLOL 81 43 28 17
ATORVASTATIN CALCIUM 79 24 29 12
COMBIVENT 78 13 30 131
CIPROFLOXACIN HCL 77 40 31 62
ESTRADIOL 76 22 R 32 181
PREDNISONE 73 37 33 40
CLONIDINE HCL 71 42 34 64
METOPROLOL SUCCINATE 67 54 35 14
OXYCODONE HCL-ACETAMINOPHEN 66 11 S2 36 83
MELOXICAM 65 40 37 28
OXAPROZIN 64 23 38 323
TRAZODONE HCL 64 31 38 43
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 35 38 73
FENTANYL 63 0 S2 41 66
MIRTAZAPINE 61 37 42 49
FLUOXETINE HCL 60 43 43 41
ALENDRONATE SODIUM 58 0 44 25
ACYCLOVIR 58 18 44 354
GEMFIBROZIL 58 14 44 108
PAROXETINE HCL 57 29 47 68
ADVAIR DISKUS 55 24 48 51
IBUPROFEN 55 16 48 89
PRAVASTATIN SODIUM 55 11 48 10
BUMETANIDE 53 19 51 121
CLOPIDOGREL 52 30 52 34
DETROL LA 52 12 52 217
HYDROXYZINE HCL 50 25 R 54 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.